Ankara Yildirim Beyazıt University
aybu.edu.trTotal trials
208
Active
42
Phase 3
0
Total enrollment
107,013
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Stroke10
- Multiple Sclerosis7
- Physical Therapy6
- Overactive Bladder5
- Anxiety5
- Athletic Performance5
- Pain5
- Virtual Reality5
Frequently asked questions about Ankara Yildirim Beyazıt University
- How many clinical trials does Ankara Yildirim Beyazıt University have on ClinicalTrials.gov?
- Ankara Yildirim Beyazıt University is listed as the lead sponsor on 208 clinical trials in ClinicalTrials.gov, 42 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ankara Yildirim Beyazıt University's trials are in Phase 3?
- 0 of Ankara Yildirim Beyazıt University's trials are in Phase 3.
- What therapeutic areas does Ankara Yildirim Beyazıt University focus on?
- Ankara Yildirim Beyazıt University's most-studied conditions on ClinicalTrials.gov are Stroke, Multiple Sclerosis, Physical Therapy, Overactive Bladder, Anxiety.